Dorff, T. B., McKay, R. R., Lowentritt, B. H., Ross, A., Cole, M., Kavati, A., Lickert, C., Zhong, Y., Ryan, M., Spratt, D. E. (2026). Testosterone suppression, safety, and adherence with relugolix in patients with metastatic prostate cancer: 6-month subgroup analysis of the OPTYX study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17057